Increased Survival With Atezolizumab in Advanced NSCLC and Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Atezolizumab in Patients With Advanced Non-Small Cell Lung Cancer and History of Asymptomatic, Treated Brain Metastases: Exploratory Analyses of the Phase III OAK Study
Lung Cancer 2019 Feb 01;128(xx)105-112, SM Gadgeel, RV Lukas, J Goldschmidt, P Conkling, K Park, D Cortinovis, F de Marinis, A Rittmeyer, JD Patel, J von Pawel, C O'Hear, C Lai, S Hu, M Ballinger, A Sandler, M Gandhi, L FehrenbacherFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.